Page results
-
The Royal National ENT Voice Centre is a national and international multidisciplinary centre for voice disorders. The voice clinic at the RNENT is one of the oldest in the UK.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
UCLH Pain Management Centre is a nationally recognized centre of excellence for people with longstanding pain.
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.
-
While you're pregnant you will have a nominated professional lead which will be a midwife or an obstetrician.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
File results
-
FOI/2021/0749 - Private contractors
-
FOI/2021/0751 - TB Find and Treat programme
-
FOI/2022/0002 - Patient Portal / Patient Access Portal system
-
FOI/2022/0007 - Priory Group services at the Trust
-
FOI/2022/0008 - Functional electrical stimulation devices
-
FOI/2022/0012 - Paediatric antibiotic guideline
-
FOI/2022/0014 - Water treatment equipment in sterile services department
-
FOI/2022/0042 - Thermometers used at Trust
-
FOI/2022/0023 - Assault attendances to ED
-
FOI/2022/0026 - Patients referred for puberty blockers/ services related to gender identity